نتائج البحث

Angiotensin-converting Enzyme 2 (ACE2) Expression in Tonsils and Adenoids (ACE2-AVG)

• Source: Study of the Expression of Angiotensin-converting Enzyme 2 (ACE2), a Cell

تفاصيل العنوان

Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) as a Treatment for Patients With COVID-19 (APN01-COVID-19)

• Source: Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) as a Treatment

تفاصيل العنوان

Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) as a Treatment for Patients With COVID-19

• Authors : Yimin LI, Director Physician

• Source: A Randomized, Open Label, Controlled Clinical Study to Evaluate the Recombinant Human Angiotensin-converting

تفاصيل العنوان

Safety and Tolerability Study of APN01 (Recombinant Human Angiotensin Converting Enzyme 2)

• Authors : Prof. Dr. Krähenbühl, Chefarzt klinische Pharmakologie & Toxikologie

• Source: Double-blind, Placebo-controlled Dose-escalation Phase I Study With Recombinant Human Soluble Angiotensin Converting

تفاصيل العنوان

Non-Insulin Dependent Diabetes Mellitus (NIDDM) and Angiotensin Converting Enzyme 2 (ACE2): Diabetic Patients Treated With Antihypertensive Drugs

• Source: ACE/ACE2 Ratio in Diabetic Patients Treated With Antihypertensive Drugs

تفاصيل العنوان

COVID-19 Blood Pressure Endothelium Interaction Study (OBELIX) (OBELIX)

• Authors : University of Glasgow

• Source: COVID-19 Blood Pressure Endothelium Interaction Study

تفاصيل العنوان

Efficacy of Vaccination Against COVID-19 in Patients Presenting a Neuromuscular Disease With Severe Amyotrophy (CANNEMUSS)

• Source: Evaluation of the Efficacy of Vaccination Against COVID-19 by Screening for Neutralizing Antibodies in Patients Presenting a Neuromuscular Disease With Severe Amyotrophy

تفاصيل العنوان

Effect of COVID-19 on Endothelial Function

• Authors : Athanasios Moulias, Principal Investigator

• Source: Effect of COVID-19 on Endothelial Function

تفاصيل العنوان

Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Inhaled APN01 Developed as Treatment for COVID-19

• Authors : Apeiron Respiratory Therapies GmbH

• Source: A Phase I, Double-blind, Placebo-controlled, Dose-escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Inhaled APN01Shoemaker RH, Panettieri RA Jr,

تفاصيل العنوان

Impact of the Genetic Polymorphism on COVID-19 in Egypt

• Authors : Misr International University; Naglaa Samir Ahmed Bazan, Ass. Professor and Acting Head of Clinical Pharmacy Department - Cairo University Hospitals

• Source: Impact of the Genetic Polymorphism on the Severity of COVID-19 Infection in Egyptian PatientsHoffmann M, Kleine-Weber H, Schroeder S, Kruger N, Herrler T, Erichsen S, Schiergens TS, Herrler G,

تفاصيل العنوان